A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
A Study Investigating Safety, Tolerability and Efficacy of UBT251 in Participants Living With Overweight or Obesity
Novo Nordisk A/S
333 participants
Feb 2, 2026
INTERVENTIONAL
Conditions
Summary
The purpose of this clinical study is to find out if UBT251 is safe and effective for treating people who are living with overweight or obesity. Participants will get either UBT251 (the treatment being tested) or Placebo (a treatment that has no active medicine in it), which treatment participants get is decided by chance.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
UBT251 injection will be administered subcutaneously in a lifted fold of the abdominal skin.
Placebo matched to UBT251 injection will be administered subcutaneously in a lifted fold of the abdominal skin.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07395687